Executive record
Alfred Novak
Public governance roles and source-backed Claims for this individual.
Alpha ID: alpha:person:alfred-novakVersion: public-0As of: 2026-09-28
Follow
More
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-28
Key Claims
Exposure
Person-level exposure is withheld from public Executive records. Published exposure, where available, attaches to the relevant Enterprise record.
Evidence, history and coverage
Additional published Claims
Published evidence records
1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
KTTA 10-K executive officers
sec filing · Source published: Mar 30, 2026 · Retrieved: May 16, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
- Executive company: Executive at Pasithea Therapeutics Corp. · Claim reviewed: May 16, 2026
- Executive title: Executive title: Director · Claim reviewed: May 16, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026
No published record changes are available in this projection.
- Roles and authority
- not observed
- Pay and holdings
- not observed
- Engagements
- not observed
- Credentials and standing
- not observed
- Exposure
- out of scope

